BRISBANE, Calif. , Oct. 13, 2025 /PRNewswire/ — ReviR Therapeutics, a biotech company focused on developing novel treatments for neurogenetic diseases, announced today that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation […]
